Equities research analysts expect that HealthStream, Inc. (NASDAQ:HSTM) will announce sales of $62.31 million for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for HealthStream’s earnings, with estimates ranging from $62.00 million to $62.62 million. HealthStream reported sales of $59.83 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 4.1%. The firm is expected to report its next quarterly earnings results on Tuesday, February 18th.
On average, analysts expect that HealthStream will report full year sales of $253.72 million for the current fiscal year, with estimates ranging from $253.40 million to $254.04 million. For the next fiscal year, analysts anticipate that the business will post sales of $253.36 million, with estimates ranging from $252.71 million to $254.00 million. Zacks’ sales averages are an average based on a survey of sell-side research firms that cover HealthStream.
HealthStream (NASDAQ:HSTM) last released its quarterly earnings data on Tuesday, October 22nd. The technology company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.06 by $0.05. The company had revenue of $62.50 million during the quarter, compared to the consensus estimate of $62.91 million. HealthStream had a net margin of 5.92% and a return on equity of 4.14%. The firm’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same period last year, the firm earned $0.09 EPS.
A number of research analysts have issued reports on the company. BidaskClub raised HealthStream from a “sell” rating to a “hold” rating in a report on Thursday, November 21st. ValuEngine downgraded shares of HealthStream from a “buy” rating to a “hold” rating in a research note on Wednesday, October 30th. Finally, Zacks Investment Research raised shares of HealthStream from a “hold” rating to a “strong-buy” rating and set a $32.00 target price on the stock in a report on Thursday, October 24th. Four analysts have rated the stock with a hold rating and one has given a strong buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $29.00.
In other news, Director Tate Deborah Taylor sold 6,495 shares of the firm’s stock in a transaction dated Thursday, October 31st. The shares were sold at an average price of $27.96, for a total value of $181,600.20. Following the transaction, the director now owns 16,181 shares of the company’s stock, valued at approximately $452,420.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 20.40% of the stock is owned by company insiders.
Several institutional investors have recently modified their holdings of the business. Jacobs Levy Equity Management Inc. raised its position in shares of HealthStream by 3.2% in the 2nd quarter. Jacobs Levy Equity Management Inc. now owns 172,700 shares of the technology company’s stock valued at $4,466,000 after acquiring an additional 5,320 shares during the period. Panagora Asset Management Inc. lifted its holdings in HealthStream by 0.6% during the second quarter. Panagora Asset Management Inc. now owns 391,521 shares of the technology company’s stock worth $10,125,000 after acquiring an additional 2,426 shares in the last quarter. Mackay Shields LLC lifted its holdings in HealthStream by 98.7% during the third quarter. Mackay Shields LLC now owns 97,626 shares of the technology company’s stock worth $2,527,000 after acquiring an additional 48,500 shares in the last quarter. Strs Ohio acquired a new position in HealthStream in the third quarter valued at about $688,000. Finally, Charles Schwab Investment Management Inc. grew its stake in HealthStream by 1.7% in the second quarter. Charles Schwab Investment Management Inc. now owns 150,039 shares of the technology company’s stock valued at $3,881,000 after acquiring an additional 2,522 shares during the period. Institutional investors own 72.34% of the company’s stock.
NASDAQ:HSTM traded up $0.05 during trading hours on Friday, reaching $28.72. The company had a trading volume of 184,596 shares, compared to its average volume of 128,016. The stock has a 50-day moving average of $27.60 and a two-hundred day moving average of $26.62. HealthStream has a one year low of $23.06 and a one year high of $30.00. The firm has a market capitalization of $943.18 million, a PE ratio of 66.79, a PEG ratio of 5.78 and a beta of 0.67. The company has a quick ratio of 2.24, a current ratio of 2.24 and a debt-to-equity ratio of 0.09.
HealthStream, Inc provides workforce and provider solutions for healthcare organizations in the United States. It operates through two segments, Workforce Solutions and Provider Solutions. The company offers workforce solutions, including software-as-a-service (SaaS) based services and subscription-based solutions to meet the training, certification, assessment, development, clinical development, talent management, performance appraisal, and other needs, as well as training, implementation, and account management services for the healthcare community.
Further Reading: Cost of Capital Explained
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.